Currently out of the existing stock ratings of Naz Rahman, 19 are a BUY (82.61%), 4 are a HOLD (17.39%).

Naz Rahman

Work Performance Price Targets & Ratings Chart

Analyst Naz Rahman, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 22.22% that have a potential upside of 14.69% achieved within 32 days.

Naz Rahman’s has documented 39 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on SCPH, Scpharmaceuticals at 20-Mar-2025.

Wall Street Analyst Naz Rahman

Analyst best performing recommendations are on PALI (PALISADE BIO).
The best stock recommendation documented was for PALI (PALISADE BIO) at 3/30/2023. The price target of $50 was fulfilled within 1 day with a profit of $10.25 (25.79%) receiving and performance score of 257.86.

Average potential price target upside

of $14.46 (90.85%) on VKTX (VIKING THERAPEUTICS).
of $53.97 (15.6%) on VRTX (VERTEX PHARMACEUTICALS).

CRXT Clarus Therapeutics Holdings PCSA Processa Pharmaceuticals VKTX Viking Therapeutics PALI Palisade Bio QNRX Quoin Pharmaceuticals Ltd DRC SCPH Scpharmaceuticals AGRX Agile Thrpe VRTX Vertex Pharmaceuticals ALIM Alimera Sciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Serge Belanger (NEEDHAM)